The US FDA's Good Manufacturing Practices Inspection of Piramal Pharma Limited's Digwal facility was completed successfully, the company said through an exchange filing.
The inspection that was held from March 27 to 31 was completed successfully with Zero Form-483 observations.
The company in an exchange filing said, "The company is committed to maintaining the highest standards of compliance."
Last news about this category
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy